Clinical Trial Update: Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Children [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the safety and immune response of a meningococcal vaccine in healthy children, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• Meningococcal vaccine (Neisseria meningitidis vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Prevention of Meningococcal Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-02-11